HRD related signature 3 predicts clinical outcome in advanced tubo-ovarian high-grade serous carcinoma
Keywords
Homologous-recombination-deficiency (HRD)
High-grade serous ovarian cancer (HGSC)
Whole-genome-sequencing (WGS)
Genetic testing
Platinum
Data availability
Raw DNA sequencing data is archived at the European Genome-phenome Archive (EGA) under study accession number EGAS00001006775.
© 2023 The Authors. Published by Elsevier Inc.
Comments (0)